This is the text extract for Schedule Update - effective 1 May 2007, browse documents here.

---

New Zealand Pharmaceutical Schedule

Effective 1 May 2007

Section H cumulative for April and May 2007

---

Contents

Summary of PHARMAC decision effective 1 May 2007.................................. 3 Print from database ...................................................................................... 4 Norfloxacin .................................................................................................... 4 Midazolam – widened access ........................................................................ 4 Clopidogrel Special Authority Approvals Timeframes .................................... 4 Looking Forward ........................................................................................... 5 Tender News .................................................................................................. 5 Sole Subsidised Supply products cumulative to May 2007 ............................ 6 New Listings ................................................................................................ 15 Changes to Restrictions ............................................................................... 16 Changes to Subsidy and Manufacturer’s Price............................................. 18 Changes to Brand Name ............................................................................. 19 Changes to Sole Subsidised Supply ............................................................. 19 Delisted Items ............................................................................................. 20 Items to be Delisted .................................................................................... 21 Section H changes to Part II ........................................................................ 22 Index ........................................................................................................... 24

---

Summary of PharmaC decisions

effeCtive 1 maY 2007 New listing (pages 15) • Salbutamol (Asthalin) nebuliser soln, 1 mg per ml, 2.5 ml and 2 mg per ml, 2.5 ml – available on a PSO Changes to restriction (pages 16-17) • Candesartan (Atacand) tab 4 mg, 8 mg, 16 mg and 32 mg – amended Special Authority criteria • Losartan (Cozaar) tab 12.5 mg, 50 mg and 100 mg – amended Special Authority criteria • Oestradiol with levonorgestrel (Nuvelle) tab 2 mg with 75 µg levonorgestrel (36) and tab 2 mg oestradiol (48) – amended presentation description • Cyclizine hydrochloride tab 50 mg – removal of additional subsidy by Special Authority • Midazolam (Hypnovel) inj 1 mg per ml, 5 ml and 5 mg per ml, 3 ml – removal of Special Authority • Mitomycin C inj 2 mg and 10 mg – addition of Section 29 criteria Decreased subsidy (page 18) • Erythropoietin alpha (Eprex) inj human recombinant pre-filled syringe 1,000 u, 2,000 u, 3,000 u, 4,000 u and 10,000 u • Roxithromycin (Romicin) tab 150 mg and 300 mg • Leflunomide (Arava) tab 10 mg, 20 mg and 100 mg • Promethazine hydrochloride (Phenergan) tab 25 mg

---

Print from database

The April 2007 edition of the Pharmaceutical Schedule has been produced using a different process. You may notice some formatting changes. Some examples of the changes include: • The Special Authority criteria are set out a bit differently • The ordering of formulations under a chemical heading is different in some cases • The contents section is now simplified and is on just one page Your feedback on these changes is welcome. Please contact us on 0800 66 00 50 or email schedule@pharmac.govt.nz with your comments.

Norfloxacin

The interpretation of the restriction for norfloxacin tablets has been amended from 1 May 2007. Currently the intention of the restriction is that if more than 6 tablets are prescribed the whole prescription is not subsidised unless the prescription is written by a specialist or on the recommendation of a specialist. From 1 May 2007 this will change. Prescriptions that are written for more than 6 tablets will attract a subsidy for 6 tablets and the balance will not be subsidised, unless the prescription is written by a specialist or on the recommendation of a specialist.

midazolam – widened access

The Special Authority criteria for midazolam inj 1 mg per ml, 5 ml and inj 5 mg per ml, 3 ml will be removed from 1 May 2007. This means that it will be able to be prescribed with no restrictions.

Clopidogrel Special authority approvals timeframes

Faxed Special Authority applications for clopidogrel are processed by HealthPAC within two working days. Electronic Special Authority applications are processed immediately. DHB hospitals can discharge patients post-stenting with up to 4 weeks supply of clopidogrel.

All decisions related to news items are effective from 1 May unless otherwise indicated

---

tender News

Sole Subsidised Supply changes – effective 1 June 2007

Chemical Name Oxytocin Oxytocin Oxytocin Sodium cromoglycate Water Presentation; Pack size Inj iu per ml, 1 ml; inj Inj 10 iu per ml, 1 ml; inj Inj iu with ergometrine maleate 00 µg per ml, 1 ml; inj Nasal spray, %; ml OP Purified for injection 20 ml; 20 inj Sole Subsidised Supply brand (and supplier) Syntocinon (Novartis) Syntocinon (Novartis) Syntometrine (Novartis) Rex (Rex) Multichem (Multichem)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 June 2007 • Aciclovir tab 200 mg (Zovirax, Acicvir), 400 mg (Acicvir) and 800 mg (Acicvir) – subsidy decrease • Clopidogrel (Plavix) tab 75 mg – subsidy and price decrease to $73.38 per 28 tab • Omeprazole (Omezol) cap 10 mg, 20 mg and 40 mg – new listing • Paroxetine hydrochloride (Aropax) tab 20 mg – removal of higher subsidy with endorsement and subsidy increase • Valaciclovir hydrochloride (Valtrex) tab 500 mg – subsidy decrease Possible decisions for implementation 1 July 2007 • Goserelin acetate (Zoladex) inj 3.6 mg and 10.8 mg - price and subsidy increase • Etanercept (Enbrel) inj 25 mg - price and subsidy decrease and Special Authority criteria amendment • Omperazole (Losec) cap 20 mg - price and subsidy decrease • Pantoprazole (Somac) tab 20 mg and 40 mg - subsidy decrease • Isradipine (Dynacirc-SRO) cap long-acting 2.5 mg and 5 mg - new listing

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Acetazolamide Acipimox Acitretin Allopurinol Amitriptyline Amlodipine Apomorphine hydrochloride Amoxycillin

Presentation

Tab 0 mg Cap 0 mg Cap 10 mg & mg Tab 100 mg & 00 mg Tab 10 mg, mg & 0 mg Tab mg & 10 mg Inj 10 mg per ml, 1 ml Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Inj 0 mg, 00 mg & 1 g Cap 0 mg & 00 mg Device Cream Tab 100 mg Tab, dispersible 00 mg Tab 0 mg & 100 mg Inj 00 µg, 1 ml Inj 100 µg, 1 ml Eye drops 1% Metered aqueous nasal spray 0 µg Metered aqueous nasal spray 100 µg Scalp app 0.1% Crm 0.1% Oint 0.1% Eye drops 0.% Eye drops 0.% Tab 00 mg Tab mg Suppos 10 mg Tab . mg & 10 mg Inj 0.%, ml Inj 0.%, 8% glucose, ml Tab mg & 10 mg Lotion BP Crm, aqueous, BP Cap 0.25 µg & 0.5 µg Tab dispersible . g Tab 1. g Tab 1. g

Brand Name Expiry Date*

Diamox Olbetam Neotigason Progout Amitrip Calvasc Mayne Ranbaxy Amoxicillin Ranbaxy Amoxicillin Ibiamox Apo-Amoxi Ortho Multichem Apo-Ascorbic Acid Ethics Aspirin Loten AstraZeneca AstraZeneca Atropt Alanase Alanase Beta Scalp Beta Cream Beta Ointment Betoptic Betoptic S Fibalip AFT, Lax-Tabs Fleet Alpha-Bromocriptine Marcain Isobaric Marcain Heavy Pacific Buspirone ABM ABM Calcitriol-AFT Calci-Tab Effervescent Calci-Tab 00 Calci-Tab 00 008 008 008 008 008 008 009 2009 008 007 008 008 009 007 009 009 008 009 009 008 007 008 007 008 007 007 009 2009 008

Applicator Aqueous cream Ascorbic acid Aspirin Atenolol Atropine sulphate

Beclomethasone dipropionate Betamethasone valerate

Betaxolol hydrochloride Bezafibrate Bisacodyl Bromocriptine mesylate Bupivacaine hydrochloride Buspirone hydrochloride Calamine Calcitriol Calcium carbonate

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated.

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Ceftriaxone sodium Celiprolol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate

Presentation

Inj 0 mg Tab 1. mg, mg & 0 mg Cap 0 mg Grans for oral liq 125 mg per 5 ml Inj 00 mg & 1 g Inj 00 mg & 1 g Tab 00 mg Oral liq 1 mg per ml Tab 10 mg Eye drops 0.% Eye oint 1% Handrub 1% with ethanol 70% Mouthwash 0.% Soln % Tab mg Tab 1. mg (0,000 iu) Tab 0 mg, 00 mg & 70 mg Tab 0 mg Cap hydrochloride 10 mg Inj phosphate 10 mg per ml, ml Crm 0.0% Scalp app 0.0% Oint 0.0% Tab 00 µg & mg TDDS . mg, 100 µg per day TDDS mg, 00 µg per day TDDS 7. mg, 00 µg per day Tab µg Tab 10 µg Inj 10 µg per ml, 1 ml Vaginal crm 1% with applicators Vaginal crm % with applicators Crm 1% Tab 1 mg, 0 mg & 0 mg Powder for soln for oral use 5 g Oral liq sugar-free trimethoprim 40 mg and sulphamethoxazole 00 mg per ml Tab trimethoprim 80 mg and sulphamethoxazole 00 mg Tab 50 mg

Brand Name Expiry Date*

Calcium Folinate Ebewe Apo-Captopril Ranbaxy-Cefaclor Ranbaxy-Cefaclor m-Cefazolin AFT Celol Allerid C Razene Chlorsig Chlorsig Orion Orion Orion Hygroton Cal-d-Forte Cipflox Clarac Dalacin C Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS- Catapres-TTS- Dixarit Catapres Catapres Clomazol Clotrimaderm % Clomazol PSM Enerlyte Trisul 008 007 007 008 008 007 008 009 009 008 009 007 008 007 008 009 008 008 008

Chlorthalidone Cholecalciferol Ciprofloxacin Clarithromycin Clindamycin Clobetasol propionate

Clonazepam Clonidine

Clonidine hydrochloride

008

Clotrimazole

007 008 007 007 008

Codeine phosphate Compound electrolytes Co-trimoxazole

Cyclizine hydrochloride

Nausicalm

2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 7

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Cyclizine lactate Cyproterone acetate Cyproterone acetate with ethinyloestradiol Danthron with poloxamer

Presentation

Inj 0 mg per ml, 1 ml Tab 0 mg mg with ethinyloestradiol µg tab with 7 inert tablets Oral liq mg with poloxamer 00 mg per ml Oral liq 7 mg with poloxamer 1 g per ml Cap mg & 0 mg Inj 00 mg Nasal spray 10 µg per dose Inj mg per ml, 1 ml Inj mg per ml, ml Range of sizes Tab EC mg & 0 mg Tab long-acting 7 mg & 100 mg Cap 1 mg, 00 mg, 0 mg & 00 mg Tab long-acting 0 mg Tab 0 mg & 0 mg Tab . mg with atropine sulphate µg Tab long-acting 10 mg Tab 0 mg & 10 mg Tab 0 mg with total sennosides 8 mg Tab mg & mg Ointment Tab mg, 10 mg & 0 mg Inj 00 µg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 00 mg Tab 10 µg Tab µg with norethisterone 00 µg and 7 inert tab

Brand Name Expiry Date*

Valoid (AFT) Siterone Estelle- ED Codalax Codalax Forte Dantrium Mayne Desmopressin-PH&T Mayne Ortho All-flex & Ortho Coil Apo-Diclo Apo-Diclo SR Videx EC DHC Continus Dilzem Diastop Pytazen SR Coloxyl Laxsol Dosan AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin Myambutol New Zealand Medical and Scientific Norimin 009 007 008 009 008 009 009 008 007 008 008 008 007 007 008 009 009 009 008 008 009 008 008 009 007 007

Dantrolene sodium Desferrioxamine mesylate Desmopressin Dexamethasone sodium phosphate Diaphragm Dicloflenac sodium Didanosine (DDI) Dihydrocodeine tartrate Diltiazem hydrochloride Diphenoxylate hydrochloride with atropine sulphate Dipyridamole Docusate sodium Docusate sodium with sennosides Doxazosin mesylate Emulsifying ointment BP Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate Ethambutol hydrochloride Ethinyloestradiol Ethinyloestradiol with norethisterone

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 8

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Etoposide Famotidine Felodopine Ferrous fumarate Ferrous sulphate Flucloxacillin sodium

Presentation

Cap 0 mg & 100 mg Tab 0 mg & 0 mg Tab long-acting mg Tab long-acting 10 mg Tab 00 mg Oral liq 10 mg per ml Cap 0 mg & 00 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 0 mg, 10 mg & 00 mg Oint 950 μg, with fluocortolone pivalate 90 µg and cinchocaine hydrochloride mg per g Suppos 630 μg, with fluocortolone pivalate 10 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 0 mg Tab disp 0 mg, scored Inj 1. mg per 0. ml, 0. ml Inj mg per ml, 1 ml Inj 100 mg per ml, 1 ml Tab 0.8 mg & mg Inj 10 mg per ml, ml Crm % & Oint % Inj 0 mg per ml, ml Tab 80 mg Tab mg Suppos . g TDDS mg and 10 mg Oral pump spray 00 µg per dose Inj mg per ml, 1 ml Inj 0 mg per ml, 1 ml Inj 100 mg per ml, 1 ml Inj 10 iu per ml, ml Tab mg & 0 mg Powder g Rectal foam 10%, CFC-Free

Brand Name Expiry Date*

Vepesid Famox Felo ER Felo 10 ER Ferro-tab Ferro-liquid Staphlex AFT AFT Pacific Ultraproct Ultraproct 009 007 007 007 007 009

Fluconazole Fluocortolone caproate with fluocortolone pivalate and cinchocaine

008 007

Fluorometholone Fluoxetine hydrochloride Fluphenazine decanoate

Flucon Fluox Fluox Modecate Modecate Modecate Apo-Folic Acid Mayne Foban Pfizer Apo-Gliclazide Minidiab PSM Nitroderm TTS Nitrolingual Pumpspray Serenace Haldol Haldol Concentrate AstraZeneca Douglas m-Hydrocortisone Colifoam Micreme H

009 007 008

Folic Acid Frusemide Fusidic Acid Gentamicin sulphate Gliclazide Glipizide Glycerol Glyceryl trinitrate Haloperidol Haloperidol decanoate Heparinised saline Hydrocortisone Hydrocortisone acetate

009 007 007 009 008 008 007 007 009 008 009 009 008 009 007

Hydrocortisone with miconazole Crm 1% with miconazole nitrate %

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Hydrocortisone with wool fat and mineral oil Hyoscine N-butylbromide Hypromellose Ibuprofen Imipramine hydrochloride Indapamide Indomethacin Ipratropium bromide

Presentation

Lotn 1% with wool fat hydrous 3% and mineral oil Inj 0 mg Eye drops 0.% Eye drops 0.% Tab 00 mg Oral liq 100 mg per ml Tab 10 mg & mg Tab . mg Cap mg & 0 mg Aerosol inhaler, 0 µg per dose CFC-free Nebuliser soln 0 µg per 1 ml, 1 ml Nebuliser soln 00 µg per ml, ml Tab long-acting 0 mg Cap 10 mg Cap 0 mg Shampoo % Tab 00 mg Oral liq 10 g per 1 ml Inj .7 mg & 11. mg Cap 0 mg with benserazide 1. mg Tab dispersible 0 mg with benserazide 1. mg Cap 100 mg with benserazide mg Cap long-acting 100 mg with benserazide mg Cap 00 mg with benserazide 0 mg Inj 0.%, ml Inj 1%, ml Inj 1%, 0 ml Crm .% with prilocaine hydrochloride .% g Crm .% with prilocaine hydrochloride .% 0g Tab mg Oral liq 1 mg per ml Tab 10 mg Tab 1 mg & . mg Paste Inj 9.% Liq 0.%

Brand Name Expiry Date*

DP Lotn HC Buscopan Poly-Tears Methopt I-Profen Fenpaed Tofranil Napamide Rheumacin Atrovent Steri-Neb Steri-Neb Duride Isotane 10 Isotane 0 Ketopine Nizoral Laevolac Lucrin Depot Madopar . Madopar Dispersible Madopar 1 Madopar HBS Madopar 0 Xylocaine 0.% Xylocaine 1.0% Xylocaine 1.0% Emla Emla Nodia Lorapaed Apo-Loratadine Ativan PSM Mayne AFT 007 007 009 007 009 007 007 008 008 008 008 007 009 009 008 008 007 009 009 008 007 007 007 009

Isosorbide mononitrate Isotretinoin Ketoconazole Lactulose Leuprorelin Levodopa with benserazide

Lignocaine hydrochloride

Lignocaine with prilocaine hydrochloride

007

Loperamide hydrochloride Loratadine Lorazepam Magnesium hydroxide Magnesium sulphate Malathion

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Maldison Maprotiline hydrochloride Medroxyprogesterone acetate Mesalazine Methadone hydrochloride Methotrexate

Presentation

Shampoo 1% Tab mg & 7 mg Inj 10 mg per ml, 1 ml syringe Enema 1 g per 100 ml Powder 1 g Tab mg Tab . mg & 10 mg Inj 100 mg per ml, ml Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 0 ml Tab 1 mg, 0 mg & 00 mg Tab long-acting 0 mg Tab mg & 0 mg Tab 10 mg Tab mg & 100 mg Crm 0.1% and oint 0.1% Inj 0 mg per ml, 1 ml Inj 0 mg per ml with lignocaine 1 ml Inj 0 mg per ml, 1 ml Inj . mg per ml, 1 ml Inj 00 mg & 1 g Inj mg per ml, ml Tab 10 mg Tab long-acting 00 mg Tab 00 mg & 00 mg Cap 0 mg Cap 0 mg & 00 mg Oral gel 0 mg per g Crm % Tab . mg & mg Tab 00 µg Tab 10 mg & 00 mg Oral liq 1 mg per ml Oral liq mg per ml Oral liq mg per ml Oral liq 10 mg per ml

Brand Name Expiry Date*

A-Lices Ludiomil Depo-Provera Pentasa AFT Pallidone Methoblastin Methotrexate Ebewe Methotrexate Ebewe Methotrexate Ebewe Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Metamide Slow-Lopressor Trichozole Metopirone Mexitil Daktarin Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph 007 009 007 009 009 007 009 008

Methyldopa Methylphenidate hydrochloride

008 009

Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate Metoclopramide hydrochloride Metoprolol tartrate Metronidazole Metyrapone Mexiletine hydrochloride Miconazole Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

009 009 008 008 009

008 007 009 007 009 008 007 008 009 009 009 009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Morphine sulphate

Presentation

Inj mg per ml, 1 ml Inj 1 mg per ml, 1 ml Cap long-acting 10 mg, 0 mg, 0 mg, 100 mg & 00 mg Tab immediate release 10 mg & 0 mg Inj 80 mg per ml, 1. ml & ml Tab 0 mg & 80 mg Eye drops 0.1% Tab 0 mg Tab 00 mg Tab long-acting 70 mg Tab long-acting 1000 mg Inj . mg per ml, 1 ml Oral suspension 10 mg per ml Tab 0 mg & 00 mg Tab long-acting 0 mg Jelly % Tab 0 µg Tab mg Tab 00 mg Tab 10 mg & mg Vaginal crm 100,000 u per g with applicators Oral liq 100,000 u per ml Cap 00,000 u Tab 00,000 u Oral liq mg per ml Tab mg Inj mg per ml, ml Inj mg per ml, 10 ml Inj mg per ml, 10 ml Tab 00 mg Suppos 1 mg & 0 mg Oral liq 10 mg per ml Oral liq 0 mg per ml Suppos 00 mg Tab 00 mg with 8 mg codeine Tab 0. mg & 1 mg Tab 100 mg Crm %

Brand Name Expiry Date*

Mayne Mayne m-Eslon Sevredol Mayne Apo-Nadolol Naphcon Forte Noflam 250 Noflam 500 Naprosyn SR 70 Naprosyn SR 1000 AstraZeneca Viramune Suspension Apo-Nicotinic Acid Nyefax Retard Gynol II Noriday 8 Primolut-N Arrow-Norfloxacin Norpress Nilstat Nilstat Nilstat Nilstat Apo-Oxybutynin Apo-Oxybutynin Pamisol Pamisol Pamisol Panadol Panadol Junior Parapaed Six Plus Parapaed Paracare Codalgin Permax Pexsig Lyderm 009 007 008 009 008 007 009 009 009 008 009 008 008 008 009 008 007 007 008 009

Morphine tartrate Nadolol Naphazoline hydrochloride Naproxen

Neostigmine Nevirapine Nicotinic acid Nifedipine Nonoxynol-9 Norethisterone Norfloxacin Nortriptyline Nystatin

Oxybutynin Pamidronate disodium

Paracetamol

008

007 008 008 009 007

Paracetamol with codeine Pergolide Perhexiline maleate Permethrin

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Pethidine hydrochloride Phenoxymethylpenicillin (Penicillin V) Pilocarpine Pindolol Poloxamer Potassium chloride

Presentation

Tab 0 mg & 100 mg Oral liq benzathine 1 mg per ml Oral liq benzathine 0 mg per ml Eye drops 0.%, 1%, %, %, % & % Tab mg, 10 mg & 1 mg Oral drops 10% Tab long-acting 00 mg Inj 7 mg per ml, 10 ml Inj 10 mg per ml, 10 ml Tab 1 mg, mg & mg Tab 1 mg, . mg, mg & 0 mg Oral liq mg per ml Cassette Inj 1. mega u Tab mg Tab 10 mg & 0 mg Cap long-acting 10 mg Tab 0 mg Tab mg, 10 mg & 0 mg Tab 10 mg with hydrochlorothiazide 1. mg Tab 0 mg with hydrochlorothiazide 1. mg Tab 00 mg Tab 00 mg Tab 10 mg & 00 mg Oral liq mg per ml Nebuliser soln, . mg with ipratropium bromide 0. mg Tab mg Crm 1% with chlorhexidine digluconate 0.% Inj 0.9%, ml & 10 ml Grans effervescent 4 g sachets Eye drops % Tab 00 mg Tab EC 00 mg Soln .% with triethanolamine lauryl sulphate and fluorescein sodium

Brand Name Expiry Date*

PSM AFT AFT Pilopt Pindol Coloxyl Span-K AstraZeneca AstraZeneca Hyprosin Apo-Prednisone Redipred MDS Quick Card Cilicaine Antinaus Cardinol Cardinol LA Apo-Pyridoxine Accupril Accuretic 10 Accuretic 0 Q 00 Q 00 Arrow Ranitidine Salapin Duolin Apo-Selegiline Silvazine AstraZeneca Ural Cromolux Salazopyrin Salazopyrin EN Pinetarsol 009 008 007 009 009 007 009 007 008 009 008 007 007 008 007 008 009 008 007 008 007 009 008 007 007 009 008 008

Prazosin hydrochloride Prednisone Prednisolone sodium phosphate Pregnancy tests - HCG urine Procaine penicillin Prochlorperazine Propranolol Pyridoxine hydrochloride Quinapril Quinapril with hydrochlorothiazide

Quinine sulphate Ranitidine hydrochloride Salbutamol Salbutamol with ipratropium bromide Selegiline hydrochloride Silver sulphadiazine Sodium chloride Sodium citro-tartrate Sodium cromoglycate Sulphasalazine Tar with triethanolamine lauryl sulphate and fluorescein

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

---

Sole Subsidised Supply Products – cumulative to May 2007

Generic Name

Temazepam Terbinafine Timolol maleate Thiamine hydrochloride Tranexamic acid Triamcinolone acetonide Triamcinolone acetonide with gramicidin, neomycin and nystatin

Presentation

Tab 10 mg Tab 0 mg Tab 10 mg Eye Drops 0.% & 0.% Tab 0 mg Tab 00 mg Crm & Oint 0.0% Dental Paste USP 0.1% Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate . mg and gramicidin 0 mcg per g Oint 1 mg with nystatin 100,000 u, neomycin sulphate . mg and gramicidin 0 µg per g Tab 1 µg Tab 0 µg Tab 00 mg Cap mg & 0 mg Cap mg Crm 10% Cap 00 mg Inj 0 mg per ml, 10 ml Tab long-acting 10 mg Inj 1 mg per ml, 1 ml Inj 1 mg per ml, ml Tab (BPC cap strength) Tab, strong, BPC Purified for injection 5 ml & 10 ml Oint BP Cap 0 mg Tab 7. mg

Brand Name Expiry Date*

Normison Apo-Terbinafine Apo-Timol Apo-Timop Apo-Thiamine Cyklokapron Aristocort Oracort Kenacomb Kenacomb 008 008 009 007 009 007 008 009 008

Triazolam Trimethoprim Trimipramine maleate Tropisetron Urea Ursodeoxycholic acid Vancomycin hydrochloride Verapamil hydrochloride Vincristine sulphate Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate Zopiclone May changes are in bold type

Hypam Hypam TMP Tripress Navoban Nutraplus Actigall Pacific Verpamil SR Mayne Mayne Healtheries Apo-B-Complex AstraZeneca Multichem Zincaps Apo-Zopiclone

008 008 008 007 008 008 008 008 009 009 009 007 008 008 008

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 1

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 May 2007

1 SALBUTAMOL Nebuliser soln, 1 mg per ml, . ml – Available on a PSO .......... .70 Nebuliser soln, mg per ml, . ml – Available on a PSO .......... .8 0 0 ✔ Asthalin ✔ Asthalin

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

1

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 May 2007

CANDESARTAN – Special Authority see SAQQQQ 070 below – Retail pharmacy ❋ Tab mg – No more than 1. tab per day ................................ 1. 0 ✔ Atacand ❋ Tab 8 mg – No more than 1. tab per day ................................ 19.0 0 ✔ Atacand ❋ Tab 1 mg – No more than 1 tab per day ................................. . 0 ✔ Atacand ❋ Tab mg – No more than 1 tab per day ................................. 8.0 0 ✔ Atacand ➽ SAQQQQ 0706 Special Authority for Subsidy Initial application only from a relevant specialist or general practitioner. Approvals valid without further renewal unless notified for applications meeting the following criteria: Either: 1 Both: 1.1 Patient with congestive heart failure; and 1.2 Either: 1..1 Has been treated with, and cannot tolerate, two ACE inhibitors, due to persistent cough; or 1.. Has experienced angioedema on an ACE inhibitor at any time in the past or who have experienced angioedema (even if not using an ACE inhibitor) in the last 2 years; or 2 All of the following: .1 Patient with raised blood pressure; and 2.2 Use of fully funded beta blockers or diuretics are contraindicated; or not well tolerated; or insufficient to control blood pressure adequately at appropriate doses; and 2.3 Either: ..1 Has been treated with, and cannot tolerate, two ACE inhibitors, due to persistent cough; or .. Has experienced angioedema on an ACE inhibitor at any time in the past or who have experienced angioedema (even if not using an ACE inhibitor) in the last 2 years. Renewal – (Previous approval has expired) only from a relevant specialist or general practitioner. Approvals valid without further renewal unless notified where the treatment remains appropriate and the patient is benefiting from treatment.

LOSARTAN – Special Authority see SAQQQQ 070 below – Retail pharmacy ❋ Tab 1. mg ........................................................................... .8 0 ✔ Cozaar ❋ Tab 0 mg ............................................................................. 1.79 0 ✔ Cozaar ❋ Tab 100 mg ........................................................................... .0 0 ✔ Cozaar ➽ SAQQQQ 0706 Special Authority for Subsidy Initial application only from a relevant specialist or general practitioner. Approvals valid without further renewal unless notified for applications meeting the following criteria: Either: 1 Both: 1.1 Patient with congestive heart failure; and 1.2 Either: 1..1 Has been treated with, and cannot tolerate, two ACE inhibitors, due to persistent cough; or 1.. Has experienced angioedema on an ACE inhibitor at any time in the past or who have experienced angioedema (even if not using an ACE inhibitor) in the last 2 years; or 2 All of the following: .1 Patient with raised blood pressure; and 2.2 Use of fully funded beta blockers or diuretics are contraindicated; or not well tolerated; or insufficient to control blood pressure adequately at appropriate doses; and 2.3 Either: ..1 Has been treated with, and cannot tolerate, two ACE inhibitors, due to persistent cough; or .. Has experienced angioedema on an ACE inhibitor at any time in the past or who have experienced angioedema (even if not using an ACE inhibitor) in the last 2 years. Renewal – (Previous approval has expired) only from a relevant specialist or general practitioner. Approvals valid without further renewal unless notified where the treatment remains appropriate and the patient is benefiting from treatment. Patients pay a manufacturer’s surcharge when S29 Unapproved medicine supplied under Section 9 the Manufacturer’s Price is greater than the Subsidy Sole Subsidised Supply ‡ safety cap reimbursed

1

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2007 (continued)

80 OESTRADIOL WITH LEVONORGESTREL – See prescribing guideline on page 78 ❋ Tab mg with 7 µg levonorgestrel (36 1) and tab mg oestradiol (48 1) ........................................... 1.0 8

✔ Nuvelle

11

CYCLIZINE HYDROCHLORIDE – Additional subsidy by Special Authority see SA0178 below – Retail pharmacy Tab 0 mg ............................................................................... 1.99 10 ✔ Nausicalm ➽ SA0178 Special Authority for Manufacturers Price Initial application from any medical practitioner. Approvals valid for 6 months where the patient is terminally ill and requires control of nausea and vomiting. Renewal from any medical practitioner. Approvals valid for 6 months where the treatment remains appropriate and the patient is benefiting from treatment. MIDAZOLAM Inj 1 mg per ml, ml – Special Authority see SA000 below – Hospital pharmacy [HP] .................................................. 1. 10 ✔ Hypnovel Inj mg per ml, ml – Special Authority see SA000 below – Hospital pharmacy [HP] ................................................. 1.00 ✔ Hypnovel ➽ SA0050 Special Authority for Subsidy Initial application only from a relevant specialist. Approvals valid for 2 years where the patient is terminally ill. Renewal only from a relevant specialist. Approvals valid for 2 years where the patient is terminally ill. MITOMYCIN C – PCT only – Specialist Inj mg ................................................................................. 8.0 Inj 10 mg ............................................................................. 10.

11

10

1 1

✔ Mitomycin-C S29 ✔ Mitomycin-C S29

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

17

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 May 2007

9 ERYTHROPOIETIN ALPHA – Special Authority see SA0 – Hospital pharmacy [HP] (ê subsidy) Inj human recombinant 1,000 u pre-filled syringe .................... 0.8 (1.90) Eprex Inj human recombinant 2,000 u, pre-filled syringe ................. 11. (.80) Eprex Inj human recombinant 3,000 u, pre-filled syringe ................. 18. (.) Eprex Inj human recombinant 4,000 u, pre-filled syringe ................. .7 (7.0) Eprex Inj human recombinant 10,000 u, pre-filled syringe ............... 08.1 (1,.8) Eprex SUNSCREENS, PROPRIETARY – Retail pharmacy-Specialist (ê price) Lotn .......................................................................................... .80 (8.8) OESTRADIOL (ê price) ❋ TDDS 3.9 mg (releases 50 μg of oestradiol per day) ................. .1 (.0) a) Higher subsidy of $13.18 per 4 with Special Authority see SA0312 b) No more than 1 patch per week c) Only on a prescription OESTRADIOL (è price) ❋ TDDS 7.8 mg (releases 100 μg of oestradiol per day) ............... 7.0 (.00) a) Higher subsidy of $16.14 per 4 with Special Authority see SA0312 b) No more than 1 patch per week c) Only on a prescription ROXITHROMYCIN (ê subsidy) Tab 10 mg ............................................................................. 9.0 (1.9) Tab 00 mg ........................................................................... 18.00 1 ml OP Aquasun Sensitive SPF 0+ Femtran 0

9

79

79

Femtran 100

88

0 0 Romicin ✔ Romicin ✔ Arava ✔ Arava ✔ Arava

101

LEFLUNOMIDE – Special Authority see SA0 below – Retail pharmacy (ê subsidy) Tab 10 mg ............................................................................. 79.7 0 Tab 0 mg ........................................................................... 108.0 0 Tab 100 mg ........................................................................... . SODIUM CALCIUM EDETATE (è price) ❋ Inj 00 mg per ml, ml .......................................................... .1 (1.71) PROMETHAZINE HYDROCHLORIDE (ê subsidy) ❋ Tab mg ................................................................................ . (8.1) .0 (1.7)

S29

1

Calcium Disodium Versenate Phenergan 0 Phenergan

1

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

18

Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Brand Name

Effective 1 May 2007

9 SUNSCREENS, PROPRIETARY – Retail pharmacy-Specialist Lotn ......................................................................................... .80 (8.8) 1 ml OP Aquasun Sensitive SPF 30+ Aquabloc 0+ 100 100 ✔ D-Penamine (S29) ✔ D-Penamine (S29)

101

PENICILLAMINE – Retail pharmacy-Specialist Tab 1 mg ........................................................................... 1.9 Tab 0 mg ........................................................................... 98.98 MITOMYCIN C – PCT only – Specialist Inj mg ...................................................................................... 8.0 Inj 10 mg .................................................................................. 10.

10

1 1

✔ Mitomycin-C Kyowa S29 ✔ Mitomycin-C Kyowa S29

Changes to Sole Subsidised Supply

Effective 1 May 2007

For the list of new Sole Subsidised Supply products effective 1 May 2007 refer to the bold entries in the cumulative Sole Subsidised Supply table pages -1.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

19

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 May 2007

CALCITRIOL – Retail pharmacy-Specialist ❋ Cap 0. µg ........................................................................... 1. (.) ❋ Cap 0. µg ............................................................................. .9 (87.98) AMOXYCILLIN Grans for oral liq 125 mg per 5 ml – Available on a PSO ............ 1.00 (1.08) Grans for oral liq 250 mg per 5 ml – Available on a PSO ............ 1.7 (1.8) CYCLIZINE HYDROCHLORIDE Tab 0 mg ............................................................................... 1. (.0) CARBOPLATIN – PCT only – Specialist Inj 10 mg per ml, 1 ml .......................................................... 0.00 Inj 10 mg per ml, ml .......................................................... 7.00 VINORELBINE – PCT only – Specialist – Special Authority see SA0799 Inj 10 mg per ml, 1 ml .......................................................... 11.00 Inj 10 mg per ml, ml .......................................................... 0.00 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab mg ................................................................................. 1.1 (.7) 100 Rocaltrol 100 Rocaltrol 100 ml Ospamox 100 ml Ospamox 10 Marzine 1 1 1 1 0 Polaramine ✔ Mayne ✔ Mayne ✔ Navelbine ✔ Navelbine

88

11

1

1

1

continued... Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

S29

0

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 August 2007

88 ROXITHROMYCIN Tab 10 mg ............................................................................. 9.0 (1.9) Tab 00 mg ........................................................................... 18.00 PROMETHAZINE HYDROCHLORIDE ❋ Tab 10 mg ............................................................................... .7 (8.8) ❋ Tab mg ............................................................................... . (8.1) .0 (1.7) 0 0 0 Phenergan Phenergan 0 Phenergan Romicin ✔ Romicin

1

Effective 1 November 2007

100 TIAPROFENIC ACID – Additional subsidy by Special Authority see SA091 on page 99 – Retail pharmacy ❋ Cap long-acting 00 mg ........................................................... .77 (17.1) Surgam SA

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

1

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Section H changes to Part II

Effective 1 May 2007

LEFLUNOMIDE Tab 10 mg......................................Arava Tab 0 mg......................................Arava Tab 100 mg....................................Arava SALBUTAMOL Nebuliser soln, 1 mg per ml, . ml ........................................Asthalin Nebuliser soln, mg per ml, . ml ........................................Asthalin 79.7 108.0 . 0 0

.70 .8

0 0

1% 1%

Jul-07 Jul-07

Ventolin Nebules Ventolin Nebules

Effective 1 April 2007

CANDESARTAN (ê price) Tab mg........................................Atacand Tab 8 mg........................................Atacand Tab 1 mg......................................Atacand Tab mg......................................Atacand CEFTAZIDIME Inj 1 g.............................................Mayne Inj g.............................................Mayne EMTRICITABINE Cap 00 mg ...................................Emtriva HEPARIN WITH SODIUM CHLORIDE Inf 25,000 iu with 0.9% sodium chloride, 0 ml .........................Baxter Inf 25,000 iu with 0.9% sodium chloride, 00 ml .........................Baxter ONDANSETRON HYDROCHLORIDE (new listing) Inj mg per ml, ml ......................Mayne Inj mg per ml, ml ......................Mayne 1. 19.0 . 8.0 9.00 18.00 07.0 0 0 0 0 1 1 0

7. 7.7 18.00 9.00

1 1

ONDANSETRON HYDROCHLORIDE (amended description) Inj 2 mg per ml, 2 ml mg per ml amp .............................Zofran 32.86 Inj 2 mg per ml, 4 ml 8 mg per ml amp .............................Zofran 70.39 PAROXETINE HYDROCHLORIDE Tab 0 mg......................................Loxamine .90

5 5 0 1% Jul-07 Apo-Paroxetine Aropax Luxotine

SUMATRIPTAN Tab 0 mg......................................Arrow-Sumatriptan1.00 Tab 100 mg....................................Arrow-Sumatriptan1.00 Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 9 Sole Subsidised Supply ‡ safety cap reimbursed

---

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Section H changes to Part II - effective 1 May 2007 (continued)

TENOFOVIR DISOPROXIL FUMARATE Tab 00 mg....................................Viread 1.00 0

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

---

Index

Pharmaceuticals and brands A Amoxycillin ........................................................ 0 Aquabloc 0+ ................................................... 19 Aquasun Sensitive SPF 0 + ....................... 18, 19 Arava ........................................................... 18, Arrow-Sumatriptan ............................................. Asthalin ....................................................... 1, Atacand ....................................................... 1, C Calcitriol ............................................................ 0 Calcium Disodium Versenate .............................. 18 Candesartan................................................. 1, Carboplatin ........................................................ 0 Ceftazidime ........................................................ Cozaar ............................................................... 1 Cyclizine hydrochloride ................................ 17, 0 D D-Penamine (S9) ............................................. 19 Dextrochlorpheniramine maleate ......................... 0 E Emtricitabine ...................................................... Emtriva .............................................................. Eprex ................................................................. 18 Erythropoietin alpha............................................ 18 F Femtran 100 ...................................................... 18 Femtran 0 ........................................................ 18 H Heparin with sodium chloride ............................. Hypnovel ........................................................... 17 L Leflunomide ................................................. 18, Losartan ............................................................ 1 Loxamine ........................................................... M Marzine.............................................................. 0 Midazolam ......................................................... 17 Mitomycin-C ...................................................... 19 Mitomycin-C Kyowa ........................................... 17 Mitomycin C ...................................................... 17 N Nausicalm.......................................................... 17 Navelbine ........................................................... 0 Nuvelle............................................................... 17 O Oestradiol .......................................................... 18 Oestradiol with levonorgestrel ............................. 17 Ondansetron hydrochloride................................. Ospamox ........................................................... 0 P Paroxetine hydrochloride .................................... Penicillamine...................................................... 19 Phenergan ................................................... 18, 1 Polaramine......................................................... 0 Promethazine hydrochloride ......................... 18, 1 R Rocaltrol ............................................................ 0 Romicin ....................................................... 18, 1 Roxithromycin.............................................. 18, 1 S Salbutamol................................................... 1, Sodium calcium edetate ..................................... 18 Sumatriptan ....................................................... Sunscreens, proprietary ............................... 18, 19 Surgam SA ........................................................ 1 T Tenofovir disoproxil fumarate ............................. Tiaprofenic acid ................................................. 1 V Vinorelbine ......................................................... 0 Viread ................................................................ Z Zofran ................................................................